 Michael Mesches
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory Disorders | 3 | 2008 | 155 | 0.330 |
Why?
| | Hippocampus | 5 | 2023 | 693 | 0.240 |
Why?
| | Sulindac | 1 | 2004 | 17 | 0.230 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 3 | 2007 | 180 | 0.230 |
Why?
| | Aging | 5 | 2004 | 1618 | 0.220 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2004 | 102 | 0.210 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2023 | 20 | 0.210 |
Why?
| | Fear | 3 | 2008 | 292 | 0.200 |
Why?
| | Encephalitis | 1 | 2004 | 127 | 0.200 |
Why?
| | Amygdala | 3 | 1996 | 170 | 0.180 |
Why?
| | Memory | 3 | 2007 | 211 | 0.170 |
Why?
| | Seizures | 3 | 2023 | 340 | 0.160 |
Why?
| | Epilepsy | 1 | 2023 | 277 | 0.160 |
Why?
| | Long-Term Potentiation | 1 | 1999 | 145 | 0.150 |
Why?
| | Rats | 12 | 2008 | 4958 | 0.140 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1996 | 4 | 0.140 |
Why?
| | Escape Reaction | 1 | 1996 | 58 | 0.140 |
Why?
| | Taste | 1 | 1996 | 208 | 0.120 |
Why?
| | Rats, Inbred F344 | 5 | 2004 | 241 | 0.110 |
Why?
| | Maze Learning | 4 | 2008 | 86 | 0.110 |
Why?
| | Stress, Psychological | 1 | 1999 | 944 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 6 | 2007 | 2218 | 0.080 |
Why?
| | Space Perception | 1 | 2008 | 64 | 0.070 |
Why?
| | Animals | 13 | 2023 | 31694 | 0.070 |
Why?
| | Synapses | 2 | 2007 | 330 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2023 | 3531 | 0.070 |
Why?
| | Memory, Short-Term | 1 | 2008 | 225 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2007 | 211 | 0.060 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2004 | 22 | 0.060 |
Why?
| | Nootropic Agents | 1 | 2004 | 27 | 0.060 |
Why?
| | Thiazolidinediones | 1 | 2004 | 142 | 0.050 |
Why?
| | Nimodipine | 1 | 2003 | 7 | 0.050 |
Why?
| | Neuroprotective Agents | 1 | 2004 | 104 | 0.050 |
Why?
| | Nerve Growth Factor | 1 | 2003 | 27 | 0.050 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 114 | 0.050 |
Why?
| | Neural Inhibition | 2 | 2002 | 140 | 0.050 |
Why?
| | Calcium Channels, L-Type | 1 | 2003 | 107 | 0.050 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2002 | 127 | 0.050 |
Why?
| | Synaptic Transmission | 2 | 2003 | 227 | 0.050 |
Why?
| | Down-Regulation | 1 | 2004 | 594 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 228 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 299 | 0.050 |
Why?
| | Up-Regulation | 1 | 2004 | 807 | 0.050 |
Why?
| | Cerebellum | 1 | 2002 | 200 | 0.040 |
Why?
| | Norepinephrine | 2 | 2002 | 201 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 966 | 0.040 |
Why?
| | Oxidants | 1 | 1999 | 112 | 0.040 |
Why?
| | Cats | 1 | 1999 | 193 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2003 | 476 | 0.040 |
Why?
| | Antioxidants | 1 | 2002 | 530 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2002 | 460 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1279 | 0.040 |
Why?
| | Corticosterone | 1 | 1999 | 211 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 1999 | 288 | 0.040 |
Why?
| | Kainic Acid | 2 | 2008 | 31 | 0.040 |
Why?
| | Male | 10 | 2008 | 55554 | 0.040 |
Why?
| | Adenosine | 1 | 1999 | 203 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2023 | 2565 | 0.030 |
Why?
| | Electroshock | 1 | 1996 | 134 | 0.030 |
Why?
| | Action Potentials | 1 | 1999 | 406 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 988 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 1996 | 159 | 0.030 |
Why?
| | Animals, Newborn | 2 | 2008 | 778 | 0.030 |
Why?
| | Cytokines | 1 | 2002 | 1840 | 0.030 |
Why?
| | Electrophysiology | 2 | 2007 | 201 | 0.030 |
Why?
| | Bicuculline | 1 | 1993 | 21 | 0.030 |
Why?
| | Stress, Physiological | 1 | 1996 | 378 | 0.030 |
Why?
| | Amnesia | 1 | 1993 | 42 | 0.030 |
Why?
| | Midazolam | 1 | 1993 | 43 | 0.030 |
Why?
| | Benzodiazepines | 1 | 1993 | 116 | 0.030 |
Why?
| | Brain | 1 | 2003 | 2371 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2004 | 9084 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2008 | 82 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2008 | 87 | 0.020 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2007 | 5 | 0.020 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2007 | 16 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 37 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2007 | 78 | 0.020 |
Why?
| | Mice | 1 | 2023 | 14860 | 0.020 |
Why?
| | Dendrites | 1 | 2007 | 85 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2007 | 181 | 0.020 |
Why?
| | Pregnancy | 2 | 2008 | 5517 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 171 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1226 | 0.020 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 209 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 386 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1147 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2008 | 927 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1629 | 0.010 |
Why?
| | Cucumis sativus | 1 | 2002 | 2 | 0.010 |
Why?
| | Spirulina | 1 | 2002 | 4 | 0.010 |
Why?
| | Iontophoresis | 1 | 2002 | 13 | 0.010 |
Why?
| | Malus | 1 | 2002 | 10 | 0.010 |
Why?
| | Malondialdehyde | 1 | 2002 | 28 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2003 | 172 | 0.010 |
Why?
| | Anxiety | 1 | 2008 | 840 | 0.010 |
Why?
| | Calcium Channels | 1 | 2003 | 145 | 0.010 |
Why?
| | Phytotherapy | 1 | 2002 | 66 | 0.010 |
Why?
| | Purkinje Cells | 1 | 2002 | 66 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2002 | 144 | 0.010 |
Why?
| | Reaction Time | 1 | 2003 | 376 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2007 | 1018 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2003 | 156 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 344 | 0.010 |
Why?
| | Xanthines | 1 | 1999 | 15 | 0.010 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 1999 | 18 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1999 | 22 | 0.010 |
Why?
| | Theophylline | 1 | 1999 | 60 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 1999 | 140 | 0.010 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 82 | 0.010 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 1999 | 98 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2002 | 736 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2002 | 2552 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 99 | 0.010 |
Why?
| | Neural Conduction | 1 | 1993 | 78 | 0.010 |
Why?
| | Avoidance Learning | 1 | 1993 | 63 | 0.010 |
Why?
| | Receptors, GABA-A | 1 | 1993 | 82 | 0.010 |
Why?
| | Catheterization | 1 | 1993 | 159 | 0.010 |
Why?
| | Inflammation | 1 | 2002 | 2477 | 0.010 |
Why?
| | Female | 2 | 2008 | 59466 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1993 | 458 | 0.010 |
Why?
|
|
Mesches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|